SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-003683
Filing Date
2012-03-30
Accepted
2012-03-30 16:16:32
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2208526z10-k.htm 10-K 2042102
2 EX-21.1 a2208526zex-21_1.htm EX-21.1 4347
3 EX-31.1 a2208526zex-31_1.htm EX-31.1 7216
4 EX-31.2 a2208526zex-31_2.htm EX-31.2 7031
5 EX-32.1 a2208526zex-32_1.htm EX-32.1 4384
6 EX-32.2 a2208526zex-32_2.htm EX-32.2 4377
7 G474919.JPG g474919.jpg GRAPHIC 42640
8 G314308.JPG g314308.jpg GRAPHIC 53279
9 G79332.JPG g79332.jpg GRAPHIC 51627
  Complete submission text file 0001047469-12-003683.txt   2274191
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35409 | Film No.: 12729436
SIC: 2834 Pharmaceutical Preparations